Blog

Why more pharma companies outsource intermediate manufacturing is no longer just a cost question. Based on real project experience, this article explains how outsourcing intermediates ...

This article shares practical, field-based experience on designing robust analytical methods for complex intermediates, focusing on impurity identification, method robustness, and regulatory expectations.

The Rise of High-Potency Intermediates highlights a fundamental shift in pharmaceutical manufacturing, where potency-related risks emerge early at the intermediate stage. As oncology and targeted ...

This article shares real-world insights from two decades of pharmaceutical process development, focusing on how synthesis route design for complex intermediates directly impacts cost, scalability, ...